用于哮喘的沙丁胺醇-布地奈德固定剂量复方急救吸入器：MANDALA研究的通俗易懂总结
Albuterol-budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study.
作者信息
Papi Alberto, Chipps Bradley E, Beasley Richard, Panettieri Reynold A, Israel Elliot, Cooper Mark, Dunsire Lynn, Jeynes-Ellis Allison, Rees Robert, Albers Frank C, Cappelletti Christy
机构信息
Department of Respiratory Medicine, University of Ferrara Medical School, Ferrara, Italy.
The Capital Allergy and Respiratory Disease Center, Sacramento, CA, USA.
出版信息
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241232264. doi: 10.1177/17534666241232264.
This summary describes the results of a clinical study called MANDALA that was published in the in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both and in a single inhaler (known as , AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.
本摘要介绍了一项名为MANDALA的临床研究结果，该研究于2022年发表。在MANDALA研究中，研究人员观察了一种新型哮喘急救吸入器，该吸入器在一个吸入器中同时含有[具体成分1]和[具体成分2]（称为[AIRSUPRA™]）。本摘要描述了参与该研究的18岁及以上人群的研究结果。
Zotero 插件